Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (292)	12/7/1998 5:15:00 PM
From: Ariella	Read Replies (1) \| Respond to of 1386

John - my "hearsay" is that American and European firms are in the running for partnering HU-211. Ariella

To: Dr. John M. de Castro who wrote (292)	12/8/1998 7:10:00 PM
From: Ariella	Respond to of 1386

Report about BOL News December 5, 12:45 Eastern Time Multex News - Initiations, Wings of Change NEW YORK (Dec. 5) BUSINESS WIRE -Dec. 5, 1998--Farsighted investors might consider taking a fresh look at Bausch & Lomb Inc. (BOL), a leader in the growing $25 billion global eye-care market. Analysts consider eye care a growth industry due to the general aging of the population, the lack of penetration in many large international markets and the creation of important new product lines. For full article, please go to the Multex Investor Network (http://www.multexinvestor.com/magazine.asp?ref=newbuys_19981130.html) Companies mentioned: Bausch & Lomb Inc. (BOL)